Herbalife shares. They have been facing similar permit scheme criticisms from activist investor black men who by all accounts wont finish his fight against the company until it is out of business. Cheryl a move to show a herbalife is not backing down, they are now meeting three new members to the board, all of whom are carl icahn approved. He has publicly sided with herbalife in the battle. Charlie gasparino is here now with exclusive details of what has been happening. Charlie this is over the past couple of days what they say his intentions are. Here is what they are saying. I actually did ask some of these people does carl icahn believe, does he have any doubt whatsoever herbalife is a company that is legal, it is not a pyramid scheme. Their words, carl is 99 sure herbalife is the real thing, it is not a pyramid scheme. A 1 possibility . It is impossible to have 100 certainty, but he tells people he is 99 sure this company is legal and it will survive. Herit is also what the Company
Box still has not turned a profit and is losing more money than it is making. With me is our tech editor ari levy as well as leslie picker in new york. Joining us via skype is the director of a financial resource company. Francis, what is your take on these numbers . I look to a lot of the Cloud Companies focused on enterprise software. I look at the quarterly earnings, loss, and sales. For the most recent quarter, they had less than 40 million in revenue. Their loss was more than 40 million. They are riding the wave of the Cloud Company hysteria. I think they want to be dropbox, but i think it is premature. I did speak to aaron levie, the ceo of box, about the timing of the ipo. He has always said 2014 is the year. Take a listen to a portion of that interview. Ipo is on the path. You told us 2014. Are you still on track for that . I have said words like it could happen that year. I think i would still use those words. He is one of the more colorful ceos in the tech community. Ari, wha
Drive retail airlines out of business. Welcome to Market Makers. I am scarlet fu. Some breaking news. New home Sales Numbers are just coming out. Lets head out to mike mckee who is in our newsroom. What do you see . The expected in new home sales, they fell by 3. 2 . That was not different than what people thought. Is interesting that happened that january was about growth. It had been stronger than people thought going in. 455. T falls to the drop is a little less than it wouldve ordinarily been. Everybody is going to write that off to the weather. February, that a still stronger than what we saw last re wasnt a the weather problem. Rates may be more important than the weather. We may see a comeback. Tosumer confidence, we want follow this closely. If the weather had an effect, it might show up here. People get more concerned about confidencesumer rises more than expected. It is a big jump over the month. People think that things are going to get better. The Expectations Index increas
That and more for nightly Business Report for march 24th. Good evening, everyone. Welcome. Biotechnology known for breakthrough therapies, it may be the most exciting businesses of the 21st century. Medicines that could improve and save lives of millions. With names like cellgene, amgen are among market leaders, especially on the nasdaq but not the past two days. Down sharply on friday, partly no response to reports an influential congressman questioned the drugs pricing. The stocks tumbled again today. The biotech index was off 3 today alone. That had a big impact on the markets overall, which were able to close well off the lows of the session. The dow up as much as 80 points as one time, down as much as 7 ask finished 26 points lower. The nasdaq down by 50, more than a 1 decline. The s p lost five. Sheila looking at what is driving the sell off of the bioteches. The sell offs started last week after Congressional Democrats sent a letter asking for more information about its pricey d
That and more for nightly Business Report for march 24th. Good evening, everyone. Welcome. Biotechnology known for breakthrough therapies, it may be the most exciting businesses of the 21st century. Medicines that could improve and save lives of millions. With names like cellgene, amgen are among market leaders, especially on the nasdaq but not the past two days. Down sharply on friday, partly no response to reports an influential congressman questioned the drugs pricing. The stocks tumbled again today. The biotech index was off 3 today alone. That had a big impact on the markets overall, which were able to close well off the lows of the session. The dow up as much as 80 points as one time, down as much as 7 ask finished 26 points lower. The nasdaq down by 50, more than a 1 decline. The s p lost five. Sheila looking at what is driving the sell off of the bioteches. The sell offs started last week after Congressional Democrats sent a letter asking for more information about its pricey d